Albendazole versus metronidazole treatment of adult giardiasis: An open randomized clinical study

Basit Öğe Kaydı
dc.authorid0000-0003-1514-1685
dc.authorid0000-0003-2005-0737
dc.authorid0000-0003-2541-4675
dc.authorid0000-0003-2342-7042
dc.contributor.authorKarabay, Oguz
dc.contributor.authorTamer, Ali
dc.contributor.authorGündüz, Hüseyin
dc.contributor.authorKayaş, Derya
dc.contributor.authorArınç, Hüseyin
dc.contributor.authorÇelebi, Harika
dc.date.accessioned2021-06-23T18:54:37Z
dc.date.available2021-06-23T18:54:37Z
dc.date.issued2004
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractAim: To investigate the efficacy and tolerability of albendazole and metranidazole treatment in giardiasis. Methods: The open comparative randomized trial was carried out prospectively from December 1999 to July 2001 in Duzce City of Turkey. The diagnosis was based on the presence of signs and symptoms compatible with giardiasis including a positive stool examination of giardia cysts or trophozoite. Metranidazole group consisted of 29 patients and was given metranidazole 500 mg, three times a day for 5 d and albendazole group was consisted of 28 patients and was given albendazole 400 mg/d for 5 d. Results: There were no significant differences in demographical and therapeutical effects and patient's compliance between both groups. But side effects were seen more in metranidazole group than in albendazole group. Conclusion: Albendazole is as effective as metranidazole in adults' giardiasis. Albendazole has less side effect potentials than metranidazole in the treatment of giardiasis. Copyright © 2004 by The WJG Press.en_US
dc.identifier.doi10.3748/wjg.v10.i8.1215
dc.identifier.endpage1217en_US
dc.identifier.issn1007-9327
dc.identifier.issue8en_US
dc.identifier.pmid15069729en_US
dc.identifier.scopus2-s2.0-2342426511en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage1215en_US
dc.identifier.urihttps://doi.org/10.3748/wjg.v10.i8.1215
dc.identifier.urihttps://hdl.handle.net/20.500.12491/4510
dc.identifier.volume10en_US
dc.identifier.wosWOS:000208097600028en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorKarabay, Oguz
dc.institutionauthorTamer, Ali
dc.institutionauthorGündüz, Hüseyin
dc.institutionauthorArınç, Hüseyin
dc.institutionauthorÇelebi, Harika
dc.institutionauthor
dc.institutionauthor
dc.language.isoenen_US
dc.publisherWJG Pressen_US
dc.relation.ispartofWorld Journal of Gastroenterologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keywords]en_US
dc.titleAlbendazole versus metronidazole treatment of adult giardiasis: An open randomized clinical studyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
oguz-karabay.pdf
Boyut:
68.65 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin/ Full text
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Cerrahi Tıp Bilimleri Bölümü Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu